US Edition
HistoSonics's #HOPE4KIDNEY trial completes patient enrolment - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
HistoSonics's #HOPE4KIDNEY trial completes patient enrolment - Interventional News
Edison HistoSonics has announced that it has completed enrolment in a pivotal trial to evaluate its histotripsy platform in treating kidney tumours. The US company’s prospective, multicentre, single-arm pivotal #HOPE4KIDNEY trial is designed to evaluate the effectiveness and safety of the Edison system for the destruction of kidney tissue by treating primary solid renal tumours. A total of 67 patients have been enrolled with a single, non-metast…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
